Bliss GVS Pharma Limited has informed the Exchange regarding Board meeting held on July 29, 2025, has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. A copy of the unaudited standalone and consolidated financial results along with the Limited Review Report of the Auditors.